The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Functional Mineralocorticoid Receptors in Human Vascular Endothelial Cells Regulate Intercellular Adhesion Molecule-1 Expression and Promote Leukocyte Adhesion
Open accessAbstract
In clinical trials, aldosterone antagonists decrease cardiovascular mortality and ischemia by unknown mechanisms. The steroid hormone aldosterone acts by binding to the mineralocorticoid receptor (MR), a ligand-activated transcription factor. In humans, aldosterone causes MR-dependent endothelial cell (EC) dysfunction and in animal models, aldosterone increases vascular macrophage infiltration and atherosclerosis. MR antagonists inhibit these effects without changing blood pressure, suggesting a direct role for vascular MR in EC function and atherosclerosis. Whether human vascular ECs express functional MR is not known. Here, we show that human coronary artery and aortic ECs express MR mRNA and protein and that EC MR mediates aldosterone-dependent gene transcription. Human ECs also express the enzyme 11-β-hydroxysteroid dehydrogenase-2 (11βHSD2), and inhibition of 11βHSD2 in aortic ECs enhances gene transactivation by cortisol, supporting that EC 11βHSD2 is functional. Furthermore, aldosterone stimulates transcription of the proatherogenic leukocyte–EC adhesion molecule intercellular adhesion molecule (ICAM)1 gene and protein expression on human coronary artery ECs, an effect inhibited by the MR antagonist spironolactone and by MR knock down with small interfering RNA. Cell adhesion assays demonstrate that aldosterone promotes leukocyte–EC adhesion, an effect that is inhibited by spironolactone and ICAM1 blocking antibody, supporting that aldosterone induction of EC ICAM1 surface expression via MR mediates leukocyte–EC adhesion. These data show that aldosterone activates endogenous EC MR and proatherogenic gene expression in clinically important human ECs. These studies describe a novel mechanism by which aldosterone may influence ischemic cardiovascular events and support a new explanation for the decrease in ischemic events in patients treated with aldosterone antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,750
Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255690.03436.ae · Cited by 1,257
Adhesion molecules and atherosclerosis
Blankenberg, S., Barbaux, S., & Tiret, L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00097-2 · Cited by 1,080
Ushio-Fukai, M., Zafari, A. M., Fukui, T., Ishizaka, N., & Griendling, K. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23317 · Cited by 767
Cronstein, B. N., Kimmel, S. C., Levin, R. I., Martiniuk, F., & Weissmann, G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.9991 · Cited by 725
Mollnau, H., Wendt, M., Szöcs, K., Lassègue, B., Schulz, E., Oelze, M., Li, H., Bodenschatz, M., August, M., Kleschyov, A. L., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000012569.55432.02 · Cited by 676
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades
Hubbard, A. K., & Rothlein, R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00223-9 · Cited by 594
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 571
Aldosterone-Induced Inflammation in the Rat Heart
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., & Weber, K. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64454-9 · Cited by 567
Farquharson, C. A. J., & Struthers, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.6.594 · Cited by 532
Human vascular smooth muscle cells contain functional estrogen receptor.
Karas, R. H., Patterson, B. L., & Mendelsohn, M. E. (1994) · Circulation · doi:10.1161/01.cir.89.5.1943 · Cited by 489
Self-citationSpironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000034738.79310.06 · Cited by 399
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
Self-citationAldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Leopold, J. A., Dam, A., Maron, B. A., Scribner, A. W., Liao, R., Handy, D. E., Stanton, R. C., Pitt, B., & Loscalzo, J. (2007) · Nature Medicine · doi:10.1038/nm1545 · Cited by 346
Hatakeyama, H., Miyamori, I., Fujita, T., Takeda, Y., Takeda, R., & Yamamoto, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51084-5 · Cited by 316
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.
Lombès, M., Oblin, M. E., Gasc, J. M., Baulieu, E. E., Farman, N., & Bonvalet, J. P. (1992) · Circulation Research · doi:10.1161/01.res.71.3.503 · Cited by 309
Rocha, R., Martin-Berger, C. L., Yang, P., Scherrer, R., Delyani, J., & McMahon, E. (2002) · Endocrinology · doi:10.1210/en.2002-220120 · Cited by 308
Deficiency of Inflammatory Cell Adhesion Molecules Protects Against Atherosclerosis in Mice
Nageh, M. F., Sandberg, E. T., Marotti, K. R., Lin, A. H., Melchior, E. P., Bullard, D. C., & Beaudet, A. L. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.8.1517 · Cited by 287
Hypertension and the cortisol-cortisone shuttle
Quinkler, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030138 · Cited by 286
Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling
Pu, Q., Neves, M. F., Virdis, A., Touyz, R. M., & Schiffrin, E. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000078357.92682.ec · Cited by 255
Fejes-Tóth, G., Pearce, D., & Náray-Fejes-Tóth, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2973 · Cited by 246
Keidar, S., Kaplan, M., Pavlotzky, E., Coleman, R., Hayek, T., Hamoud, S., & Aviram, M. (2004) · Circulation · doi:10.1161/01.cir.0000127949.05756.9d · Cited by 244
FARQUHARSON, C. A. J., & STRUTHERS, A. D. (2002) · Clinical Science · doi:10.1042/cs1030425 · Cited by 224
Dansky, H. M., Barlow, C. B., Lominska, C., Sikes, J. L., Kao, C., Weinsaft, J., Cybulsky, M. I., & Smith, J. D. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1001.096625 · Cited by 219
Fiebeler, A., Schmidt, F., Müller, D. N., Park, J.-K., Dechend, R., Bieringer, M., Shagdarsuren, E., Breu, V., Haller, H., & Luft, F. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.787 · Cited by 213
Miyata, K., Rahman, M., Shokoji, T., Nagai, Y., Zhang, G.-X., Sun, G.-P., Kimura, S., Yukimura, T., Kiyomoto, H., Kohno, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040390 · Cited by 212
Macdonald, J. E., Kennedy, N., & Struthers, A. D. (2004) · Heart · doi:10.1136/hrt.2003.017368 · Cited by 141
Human Endothelium: Target for Aldosterone
Oberleithner, H., Ludwig, T. E., Riethmüller, C., Hillebrand, U., Albermann, L., Schäfer, C., Shahin, V., & Schillers, H. (2004) · Hypertension · doi:10.1161/01.hyp.0000123572.45556.a5 · Cited by 139
Rogerson, F. M., & Fuller, P. J. (2000) · Steroids · doi:10.1016/s0039-128x(99)00087-2 · Cited by 139
Mineralocorticoid Receptor Activation Promotes Vascular Cell Calcification
Jaffe, I. Z., Tintut, Y., Newfell, B. G., Demer, L. L., & Mendelsohn, M. E. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000258414.59393.89 · Cited by 131
Self-citationDeGraba, T. J., Sirén, A., Penix, L. P., McCarron, R. M., Hargraves, R. W., Sood, S. L., Pettigrew, K. D., & Hallenbeck, J. M. (1998) · Stroke · doi:10.1161/01.str.29.7.1405 · Cited by 109
Interferon-γ-induced Epithelial ICAM-1 Expression and Monocyte Adhesion
Chang, Y., Holtzman, M. J., & Chen, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109924200 · Cited by 100
Localization of 2 11β-OH Steroid Dehydrogenase Isoforms in Aortic Endothelial Cells
Brem, A. S., Bina, R. B., King, T. C., & Morris, D. J. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.459 · Cited by 99
Hope, S. A., & Meredith, I. T. (2003) · Internal Medicine Journal · doi:10.1046/j.1444-0903.2003.00378.x · Cited by 86
Subcellular Localization of the Type 2 11β-Hydroxysteroid Dehydrogenase
Náray‐Fejes‐Tóth, A., & Fejes‐Tóth, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15436 · Cited by 85
Hartig, P. C., Bobseine, K. L., Britt, B. H., Cardon, M. C., Lambright, C. R., Wilson, V. S., & Gray, L. E. (2002) · Toxicological Sciences · doi:10.1093/toxsci/66.1.82 · Cited by 84
Hope, S. A., & Meredith, I. T. (2003) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2003.00379.x · Cited by 82
Kotlyar, E., Vita, J. A., Winter, M. R., Awtry, E. H., Siwik, D. A., Keaney, J. F., Sawyer, D. B., Cupples, L. A., Colucci, W. S., & Sam, F. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.08.005 · Cited by 79
Derfoul, A., Robertson, N. M., Lingrel, J. B., Hall, D. J., & Litwack, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.20702 · Cited by 72
Mineralocorticoid selectivity: Molecular and cellular aspects
Farman, N., & Bocchi, B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00976.x · Cited by 71
Roy, J., Audette, M., & Tremblay, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005067200 · Cited by 64
The Mineralocorticoid Receptor and Oxidative Stress
Fiebeler, A., & Luft, F. C. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2348-y · Cited by 62
Galigniana, M. D. (1998) · Biochemical Journal · doi:10.1042/bj3330555 · Cited by 54
Cited by
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Brown, N. J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.110 · Cited by 451
The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
Pacurari, M., Kafoury, R., Tchounwou, P. B., & Ndebele, K. (2014) · International Journal of Inflammation · doi:10.1155/2014/689360 · Cited by 374
Aldosterone: effects on the kidney and cardiovascular system
Briet, M., & Schiffrin, E. L. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.30 · Cited by 337
Jaisser, F., & Farman, N. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011106 · Cited by 327
Targeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
Metadata
- Authors
- Caprio, M., Newfell, B. G., la Sala, A., Baur, W., Fabbri, A., Rosano, G., Mendelsohn, M. E., & Jaffe, I. Z.
- Venue
- Circulation Research
- Published
- 2008-06-06
- Volume
- 102
- Issue
- 11
- Pages
- 1359-1367
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2109560663
- Cited by
- 285
- References
- 50
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.